These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 27930735)
1. Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape. White MK; Hu W; Khalili K PLoS Pathog; 2016 Dec; 12(12):e1005953. PubMed ID: 27930735 [No Abstract] [Full Text] [Related]
2. CRISPR-Cas based targeting of host and viral genes as an antiviral strategy. Koujah L; Shukla D; Naqvi AR Semin Cell Dev Biol; 2019 Dec; 96():53-64. PubMed ID: 30953741 [TBL] [Abstract][Full Text] [Related]
3. Therapeutic potentials of CRISPR-Cas genome editing technology in human viral infections. Najafi S; Tan SC; Aghamiri S; Raee P; Ebrahimi Z; Jahromi ZK; Rahmati Y; Sadri Nahand J; Piroozmand A; Jajarmi V; Mirzaei H Biomed Pharmacother; 2022 Apr; 148():112743. PubMed ID: 35228065 [TBL] [Abstract][Full Text] [Related]
4. [The CRISPR/Cas system: a genome editing tool to develop animal models of viral infections]. Castino G; Guillemet M; Joly A; Vignon A Med Sci (Paris); 2018 May; 34(5):403-405. PubMed ID: 29900841 [No Abstract] [Full Text] [Related]
5. Harnessing CRISPR to combat human viral infections. de Buhr H; Lebbink RJ Curr Opin Immunol; 2018 Oct; 54():123-129. PubMed ID: 30056335 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Strategies of Clustered Regularly Interspaced Palindromic Repeats-Cas Systems for Different Viral Infections. Wahid B; Usman S; Ali A; Saleem K; Rafique S; Naz Z; Ahsan Ashfaq H; Idrees M Viral Immunol; 2017 Oct; 30(8):552-559. PubMed ID: 28825529 [TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9-Based Antiviral Strategy: Current Status and the Potential Challenge. Lee C Molecules; 2019 Apr; 24(7):. PubMed ID: 30959782 [TBL] [Abstract][Full Text] [Related]
11. Genome Editing Strategies to Protect Livestock from Viral Infections. Söllner JH; Mettenleiter TC; Petersen B Viruses; 2021 Oct; 13(10):. PubMed ID: 34696426 [TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas-Mediated Resistance against Viruses in Plants. Khan ZA; Kumar R; Dasgupta I Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216418 [TBL] [Abstract][Full Text] [Related]
13. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina. Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510 [TBL] [Abstract][Full Text] [Related]
14. Mitochondrial DNA modification by CRISPR/Cas system: Challenges and future direction. Prakash R; Kannan A Prog Mol Biol Transl Sci; 2021; 178():193-211. PubMed ID: 33685597 [TBL] [Abstract][Full Text] [Related]
15. Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors. Shalaby K; Aouida M; El-Agnaf O Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027946 [TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of an immortalized renal cell line of the Chinese tree shrew (Tupaia belangeri chinesis). Gu T; Yu D; Li Y; Xu L; Yao YL; Yao YG Appl Microbiol Biotechnol; 2019 Mar; 103(5):2171-2180. PubMed ID: 30637496 [TBL] [Abstract][Full Text] [Related]